Stockholders' Equity (Details) - USD ($) |
1 Months Ended | 12 Months Ended | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 10, 2020 |
May 12, 2020 |
Apr. 14, 2020 |
Mar. 12, 2020 |
Jan. 08, 2020 |
Dec. 11, 2019 |
Dec. 05, 2019 |
Nov. 11, 2019 |
Sep. 09, 2019 |
Feb. 13, 2019 |
Oct. 31, 2020 |
Aug. 31, 2020 |
Aug. 27, 2020 |
Aug. 25, 2020 |
Jun. 24, 2020 |
May 31, 2020 |
Apr. 30, 2020 |
Apr. 21, 2020 |
Apr. 16, 2020 |
Apr. 15, 2020 |
Feb. 29, 2020 |
Jan. 31, 2020 |
Dec. 23, 2019 |
Nov. 20, 2019 |
Sep. 30, 2019 |
Sep. 25, 2019 |
Sep. 16, 2019 |
Jul. 17, 2019 |
Jun. 28, 2019 |
Jan. 31, 2019 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Jan. 30, 2019 |
Dec. 19, 2018 |
|
| Stockholders’ Equity (Textual) | ||||||||||||||||||||||||||||||||||
| Common stock, shares authorized | 45,000,000 | 45,000,000 | ||||||||||||||||||||||||||||||||
| Common stock per share (in Dollars per share) | $ 6.95 | $ 0.001 | $ 0.001 | |||||||||||||||||||||||||||||||
| Value of common stock shares issued (in Dollars) | $ 36,584.80 | $ 9,896 | $ 7,391 | |||||||||||||||||||||||||||||||
| Number of shares issued | 5,264 | 9,895,600 | 7,390,261 | |||||||||||||||||||||||||||||||
| Settling of accrued expenses (in Dollars) | $ 125,000 | |||||||||||||||||||||||||||||||||
| Gain loss on settlement of accounts payable (in Dollars) | $ 717,450 | $ 7,990 | $ 17,226 | |||||||||||||||||||||||||||||||
| Transfer of common stock to consultants, description | On or about February 1, 2019, the Company’s founder and CEO as well as another shareholder transferred an aggregate of approximately 1,379,000 and 144,000 shares of common stock, respectively to certain consultants of the Company, of which approximately 983,000 and 144,000 shares of common stock, respectively were sold to consultants in exchange for promissory notes. The Company accounted for these share transfers as stock-based compensation expense based upon the Black-Scholes model as if these were stock option grants made by the Company. The Company used the following inputs in the Black-Scholes option pricing model, expected life of 5 years, risk-free interest rate of 2.51%, volatility 92% and dividend yield of 0%. As a result, the Company recognized approximately $3.6 million of stock-based compensation expense during the first quarter of 2019 related to these share transfers. Additionally, approximately 396,000 shares of common stock were transferred by the founder and CEO to contractors for no consideration. The Company accounted for these share transfers as stock-based compensation based upon the underlying common stock price of $4.37 as of the date of transfer. The Company recognized approximately $1.7 million of stock-based compensation expense related to these transfers during the first quarter of 2019. | |||||||||||||||||||||||||||||||||
| Cash payment (in Dollars) | $ 5,884,361 | |||||||||||||||||||||||||||||||||
| Issuance of shares of accounts payable | 104,567 | 100,000 | 1,401 | |||||||||||||||||||||||||||||||
| Issuance of value of accounts payable (in Dollars) | $ 93,150 | $ 640,517 | ||||||||||||||||||||||||||||||||
| Fair value of per share (in Dollars per share) | $ 5.76 | $ 6.95 | ||||||||||||||||||||||||||||||||
| Recorded a loss on settlement (in Dollars) | $ 509,160 | |||||||||||||||||||||||||||||||||
| Warrants to purchase shares of common stock, description | the Company issued 80,000 shares of common stock and warrants to purchase 100,000 shares of common stock, of which 50,000 shall be exercisable at $3.80 per share and the remaining 50,000 shall be exercisable at $5.80 per share, in each case for a term of 5 years, in connection with the termination of a consulting arrangement and in full settlement of any and all claims again the Company. The Company had previously accrued $195,000 in connection with this consulting arrangement. The stock had a fair value of $2.37 per share. | |||||||||||||||||||||||||||||||||
| Shares of common stock in full settlement of accounts payable | 140,000 | 17,000 | ||||||||||||||||||||||||||||||||
| Value of common stock in full settlement of accounts payable (in Dollars) | $ 806,400 | $ 40,800 | ||||||||||||||||||||||||||||||||
| Full settlement of accounts payable (in Dollars) | $ 88,950 | $ 48,790 | ||||||||||||||||||||||||||||||||
| Fair value of per shares (in Dollars per share) | $ 5.76 | $ 2.20 | ||||||||||||||||||||||||||||||||
| Issuance of common stock (in Dollars) | $ 36,842 | |||||||||||||||||||||||||||||||||
| Sale of stock, consideration received (in Dollars) | $ 515,000 | |||||||||||||||||||||||||||||||||
| Sale of stock, committed (in Dollars) | $ 565,000 | |||||||||||||||||||||||||||||||||
| Sale of stock, shares | 135,527 | |||||||||||||||||||||||||||||||||
| Common stock, per share (in Dollars per share) | $ 3.80 | |||||||||||||||||||||||||||||||||
| Warrants to purchase of shares | 169,409 | |||||||||||||||||||||||||||||||||
| Warrants exercise price (in Dollars per share) | $ 4.00 | |||||||||||||||||||||||||||||||||
| Shares issued for equity financing (in Dollars) | 140,000 | |||||||||||||||||||||||||||||||||
| Equity financing current liabilities (in Dollars) | 375,000 | |||||||||||||||||||||||||||||||||
| Shares, Issued | 3,000,000 | |||||||||||||||||||||||||||||||||
| Stockholders’ equity description | the Company issued 50,000 RSU’s to a member of the board of directors. The RSU’s vested immediately and had a fair value of $135,000. Additionally, on December 10, 2019, the board of directors awarded stock options under the 2016 Plan to each of the three remaining independent directors to 50,000 shares of the Company’s common stock. The stock options have a term of five years, an exercise price of $2.64 per share, vest immediately on the grant date of December 10, 2019 and had a grant date fair value of $388,746. The Company determined the fair value of the stock options using the Black-Scholes model with the following inputs: expected life 10 years, risk-free interest rate 1.0%, dividend yield 0% and expected volatility 100%. | the Board of Directors of the Company granted an aggregate of 425,000 restricted stock units (“RSUs”) under the 2016 Plan, of which an aggregate of 325,000 shares were granted to management and vest quarterly over the next three years, and of which 100,000 were issued to a consultant and vest quarterly over one year. Upon the effectiveness under the Securities Act of a registration statement on Form S-8 with respect to the shares covered by the 2016 Plan, these RSUs vest in twelve equal quarterly instalments, commencing on the grant date of February 13, 2019 and had a grant date fair value of approximately $2.7 million. The Company also granted an additional 525,000 RSUs which are subject to performance vesting, of which an aggregate of 225,000 shares were issued to management and 300,000 were issued to a consultant. The 225,000 shares issued to management were cancelled in April 2020, when the person’s employment with the Company terminated. Additionally, the board of directors awarded stock options under the 2016 Plan to each of the four independent board members to acquire an aggregate of 53,572 shares of the Company’s common stock and to an employee to acquire 25,000 shares. The stock options have a term of five years, an exercise price of $6.49 per share, vest quarterly over four quarters beginning on the grant date of February 13, 2019 and had a grant date fair value of $431,000. The Company determined the fair value of the stock options using the Black-Scholes model with the following inputs: expected life 10 years, risk-free interest rate 0.25%, dividend yield 0% and expected volatility 90%. | ||||||||||||||||||||||||||||||||
| Stock-based compensation expense (in Dollars) | $ 162,250 | |||||||||||||||||||||||||||||||||
| Unrecognized expense for unvested stock options and restricted stock awards (in Dollars) | $ 2,500,000 | $ 3,200,000 | ||||||||||||||||||||||||||||||||
| RSU [Member] | ||||||||||||||||||||||||||||||||||
| Stockholders’ Equity (Textual) | ||||||||||||||||||||||||||||||||||
| Shares issued to employee | 250,000 | |||||||||||||||||||||||||||||||||
| Warrant [Member] | ||||||||||||||||||||||||||||||||||
| Stockholders’ Equity (Textual) | ||||||||||||||||||||||||||||||||||
| Common stock per share (in Dollars per share) | $ 4.00 | |||||||||||||||||||||||||||||||||
| Cashless exercise of common stock warrants, Shares | 116,448 | 56,982 | 520,925 | |||||||||||||||||||||||||||||||
| Purchase of warrants shares | 46,053 | |||||||||||||||||||||||||||||||||
| Prior receipt equity financing (in Dollars) | $ 140,000 | |||||||||||||||||||||||||||||||||
| Common Stock [Member] | ||||||||||||||||||||||||||||||||||
| Stockholders’ Equity (Textual) | ||||||||||||||||||||||||||||||||||
| Warrants exercised | 1,283,124 | |||||||||||||||||||||||||||||||||
| Cash payment (in Dollars) | $ 1,283 | |||||||||||||||||||||||||||||||||
| Cashless exercise of common stock warrants, Shares | 68,715 | 26,034 | 321,155 | |||||||||||||||||||||||||||||||
| Common stock option exercised | 28,890 | 57,534 | ||||||||||||||||||||||||||||||||
| Shares issued for equity financing (in Dollars) | $ 38 | |||||||||||||||||||||||||||||||||
| Common Stock [Member] | Equity Option [Member] | ||||||||||||||||||||||||||||||||||
| Stockholders’ Equity (Textual) | ||||||||||||||||||||||||||||||||||
| Common stock option exercised | 55,263 | 105,028 | ||||||||||||||||||||||||||||||||
| Former Employee [Member] | ||||||||||||||||||||||||||||||||||
| Stockholders’ Equity (Textual) | ||||||||||||||||||||||||||||||||||
| Shares issued | 50,000 | 25,000 | ||||||||||||||||||||||||||||||||
| Shares issued to employee | 87,255 | 25,000 | 30,303 | 24,843 | ||||||||||||||||||||||||||||||
| Value issued to employee (in Dollars) | $ 142,226 | $ 73,250 | $ 75,000 | |||||||||||||||||||||||||||||||
| Director [Member] | ||||||||||||||||||||||||||||||||||
| Stockholders’ Equity (Textual) | ||||||||||||||||||||||||||||||||||
| Shares issued | 50,000 | |||||||||||||||||||||||||||||||||
| Value of common stock shares issued (in Dollars) | $ 135,000 | |||||||||||||||||||||||||||||||||
| Employee [Member] | ||||||||||||||||||||||||||||||||||
| Stockholders’ Equity (Textual) | ||||||||||||||||||||||||||||||||||
| Shares issued to employee | 16,667 | 3,913 | ||||||||||||||||||||||||||||||||
| Series A Convertible Preferred Stock [Member] | ||||||||||||||||||||||||||||||||||
| Stockholders’ Equity (Textual) | ||||||||||||||||||||||||||||||||||
| Shares issued | 6,579 | 200,000 | 200,000 | 13,158 | 13,158 | 51,316 | 1,043,935 | 172,369 | 5,264 | 9,211 | 73,156 | 43,081 | 65,789 | |||||||||||||||||||||
| Conversion of shares | 76,000 | 5,000 | 5,000 | 19,500 | 396,695 | 65,500 | 2,000 | 16,371 | 25,000 | |||||||||||||||||||||||||
| Stock conversion, description | On September 16, 2019, we issued 108,422 shares of our common stock to a holder of our shares of Series A Convertible Preferred Stock upon the conversion of 41,200 of such shares of Series A Convertible Preferred Stock. | |||||||||||||||||||||||||||||||||
| Value of common stock shares issued (in Dollars) | $ 21,053 | $ 584,000 | $ 26,343 | $ 250,000 | ||||||||||||||||||||||||||||||
| Common Stock [Member] | ||||||||||||||||||||||||||||||||||
| Stockholders’ Equity (Textual) | ||||||||||||||||||||||||||||||||||
| Warrants exercised | 7,000 | |||||||||||||||||||||||||||||||||
| Cash payment (in Dollars) | $ 38,570 | |||||||||||||||||||||||||||||||||
| Series A Preferred Shares [Member] | ||||||||||||||||||||||||||||||||||
| Stockholders’ Equity (Textual) | ||||||||||||||||||||||||||||||||||
| Preferred stock, shares authorized | 900,000 | 900,000 | 900,000 | |||||||||||||||||||||||||||||||
| Preferred stock, par value (in Dollars per share) | $ 0.001 | $ 0.001 | $ 0.001 | |||||||||||||||||||||||||||||||